Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Neal

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Frontiers in Neurology|April 26, 2021
Frequency, Progression, and Current Management: Report of 16 New Cases of Nonfunctional Pancreatic Neuroendocrine Tumors in Tuberous Sclerosis Complex and Comparison With Previous ReportsKate Mowrey, Hope Northrup, Peyton Rougeau, et al.
Plos One|February 26, 2013
Similar trends in serum VEGF-D levels and kidney angiomyolipoma responses with longer duration sirolimus treatment in adults with tuberous sclerosisIzabela A Malinowska, Nancy Lee, Vidhya Kumar, et al.
Journal of Child Neurology|March 2, 2012
Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndromeElizabeth D Tate, Michael R Pranzatelli, Steven J Verhulst, et al.
Aging & Mental Health|July 23, 2025
What are the unmet needs in people affected by dementia? A scoping review of reviewsWei Qi Koh, Martina Roes, Marjolein de Vugt, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 1, 2014
Leveraging technology: creating and sustaining changes for healthDeydre S Teyhen, Matt Aldag, Elton Edinborough, et al.
BJU International|March 31, 2015
Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-upEila Watson, Bethany Shinkins, Emma Frith, et al.
BMJ Open|May 24, 2014
PROSPECTIV-a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trialEila Watson, Peter Rose, Emma Frith, et al.
The Lancet. Oncology|December 3, 2014
Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 studyDavid Neal Franz, Elena Belousova, Steven Sparagana, et al.
Plos One|September 15, 2011
Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decreaseSandra L Dabora, David Neal Franz, Stephen Ashwal, et al.
The Journal of Orthopaedic and Sports Physical Therapy|May 3, 2014
Key enablers to facilitate healthy behavior change: workshop summaryDeydre S Teyhen, Matt Aldag, Damon Centola, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Frontiers in Neurology|April 26, 2021
Frequency, Progression, and Current Management: Report of 16 New Cases of Nonfunctional Pancreatic Neuroendocrine Tumors in Tuberous Sclerosis Complex and Comparison With Previous ReportsKate Mowrey, Hope Northrup, Peyton Rougeau, et al.
Plos One|February 26, 2013
Similar trends in serum VEGF-D levels and kidney angiomyolipoma responses with longer duration sirolimus treatment in adults with tuberous sclerosisIzabela A Malinowska, Nancy Lee, Vidhya Kumar, et al.
Journal of Child Neurology|March 2, 2012
Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndromeElizabeth D Tate, Michael R Pranzatelli, Steven J Verhulst, et al.
Aging & Mental Health|July 23, 2025
What are the unmet needs in people affected by dementia? A scoping review of reviewsWei Qi Koh, Martina Roes, Marjolein de Vugt, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 1, 2014
Leveraging technology: creating and sustaining changes for healthDeydre S Teyhen, Matt Aldag, Elton Edinborough, et al.
BJU International|March 31, 2015
Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-upEila Watson, Bethany Shinkins, Emma Frith, et al.
BMJ Open|May 24, 2014
PROSPECTIV-a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trialEila Watson, Peter Rose, Emma Frith, et al.
The Lancet. Oncology|December 3, 2014
Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 studyDavid Neal Franz, Elena Belousova, Steven Sparagana, et al.
Plos One|September 15, 2011
Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decreaseSandra L Dabora, David Neal Franz, Stephen Ashwal, et al.
The Journal of Orthopaedic and Sports Physical Therapy|May 3, 2014
Key enablers to facilitate healthy behavior change: workshop summaryDeydre S Teyhen, Matt Aldag, Damon Centola, et al.
Pageof 13